Learning of Pharmacogenetics in human medicine students through PBL and ICTs
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Autor
Medina, Maritza PlacenciaValencia, Javier Silva
Bustamante, Carlos García
Valerio, Julián Villarreal
Álvarez, Rosa Pando
Casavilca, Michan Malca
Contreras-Pizarro, Carlos Heber
Fecha de publicación
2022-01-01
Metadatos
Mostrar el registro completo del ítemEditorial
Universidad Politecnica de Valencia.Journal
International Conference on Higher Education AdvancesDOI
10.4995/HEAd22.2022.14674Enlaces adicionales
http://ocs.editorial.upv.es/index.php/HEAD/HEAd22/paper/view/14674Resumen
Objective: To describe the learning achievement after training in pharmacogenetics based on PBL and ICT and its persistence four years later in human medicine students of a public university in Peru. Materials and Methods: 160 students who received training on the pharmacogenetics of warfarin applying PBL and ICT were evaluated. The instrument was based on a clinical problem applied immediately after training and 4 years later. Results: Results of the first evaluation indicated a good analytical resolution of the problem with argumentation in the genetic conditions of the patient. The evaluation after four years showed that 89% of the students continued at higher levels of learning. Conclusion: It was shown that the use of a meaningful learning methodology with PBL and ICT can make knowledge last and serve in the future for decision-making in the selection of medication.Tipo
info:eu-repo/semantics/articleDerechos
info:eu-repo/semantics/openAccessAttribution-NonCommercial-ShareAlike 4.0 International
Idioma
engEISSN
26035871ae974a485f413a2113503eed53cd6c53
10.4995/HEAd22.2022.14674
Scopus Count
Colecciones
El ítem tiene asociados los siguientes ficheros de licencia:
- Creative Commons
Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/openAccess